Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amplifica, Anavex, Astellas, Bayer, Blue Earth, Caliway, Carisma, Checkpoint, Cognition, Corcept, First Wave, Foghorn, Genmab, Karyopharm, Microba, Neuren, Panbela, Prothena, Regeneron, Rezolute, Spago, Stellas, Taysha Gene Therapies, Tme, Verona, Viracta.